Chemistry and biochemistry of 2′,5′-oligoadenylate-based antisense strategy

被引:31
作者
Adah, SA
Bayly, SF
Cramer, H
Silverman, RH
Torrence, PF [1 ]
机构
[1] No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA
[2] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[3] Gemini Technol Inc, Cleveland, OH 44106 USA
[4] NIDDKD, Sect Biomed Chem, Med Chem Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.2174/0929867013372445
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review describes the application of a natural defense mechanism to develop effective agents for the post-transcriptional control of gene expression. 2-5A is a unique 2 ' ,5 ' -phosphodiester bond linked oligoadenylate, (pp)p5 ' A2 ' (p5 'A)(n) , that is elaborated in virus-infected interferon-treated cells. The 2-5A system is an RNA degradation pathway that is an important mechanistic component of interferon's action against certain viruses. It may also play a role in the anticellular effects of interferon and in general RNA decay. A major player in the 2-5A-system is the latent and constitutive 2-5A-dependent ribonuclease (RNase L) which upon activation by 2-5A, degrades RNA. This RNase I, enzyme can be recruited for antisense therapeutics by linking it to an appropriate oligonucleotide targeted to a chosen RNA. Syntheses of 2-5A, its analogues, 2-5A-antisense, and its modifications are detailed herein. Applications of 2-5A-antisense to particular targets such as HIV, PKR, chronic myelogenous leukemia, telomerase, and respiratory syncytical virus are described.
引用
收藏
页码:1189 / 1212
页数:24
相关论文
共 145 条
[1]   Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies [J].
Agrawal, S ;
Jiang, ZW ;
Zhao, QY ;
Shaw, D ;
Cai, QY ;
Roskey, A ;
Channavajjala, L ;
Saxinger, C ;
Zhang, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2620-2625
[2]   Antisense therapeutics [J].
Agrawal, S ;
Zhao, QY .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :519-528
[3]   2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection [J].
Barnard, DL ;
Sidwell, RW ;
Xiao, W ;
Player, MR ;
Adah, SA ;
Torrence, PF .
ANTIVIRAL RESEARCH, 1999, 41 (03) :119-134
[4]   Antisense oligonucleotides: Is the glass half full or half empty? [J].
Bennett, CF .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (01) :9-19
[5]   EFFECT OF DERIVATIZATION OF RIBOPHOSPHATE BACKBONE AND TERMINAL RIBOPHOSPHATE GROUPS IN OLIGORIBONUCLEOTIDES AN THEIR STABILITY AND INTERACTION WITH EUKARYOTIC CELLS [J].
BOUTORINE, AS ;
VENYAMINOVA, AG ;
REPKOVA, MN ;
SERGUEYEVA, ZA ;
PYSHNYI, DV .
BIOCHIMIE, 1994, 76 (01) :23-32
[6]   Antisense drug discovery: Can cell-free screens speed the process? [J].
Branch, AD .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (03) :249-254
[7]  
Carroll SS, 1996, J BIOL CHEM, V271, P4988
[8]   Activation of RNase L by 2',5'-oligoadenylates - Kinetic characterization [J].
Carroll, SS ;
Cole, JL ;
Viscount, T ;
Geib, J ;
Gehman, J ;
Kuo, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) :19193-19198
[9]   A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system [J].
Castelli, JC ;
Hassel, BA ;
Wood, KA ;
Li, XL ;
Amemiya, K ;
Dalakas, MC ;
Torrence, PF ;
Youle, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) :967-972
[10]   The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis [J].
Castelli, JC ;
Hassel, BA ;
Maran, A ;
Paranjape, J ;
Hewitt, JA ;
Li, XL ;
Hsu, YT ;
Silverman, RH ;
Youle, RJ .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (04) :313-320